Business Segment Information

9 Months Ended

Nov. 02, 2024

Segment Reporting [Abstract]

Business Segment Information

Note 8

Business Segment Information

Three Months Ended November 2, 2024
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	362,517	$	121,826	$	78,463		$	33,587		$	—		$	596,393
Intercompany sales elimination		—		—		—			(65	)		—			(65	)
Net sales to external customers(1)		362,517		121,826		78,463			33,522			—			596,328
Segment operating income (loss)		13,166		3,119		(91	)		3,729			(9,579	)		10,344
Asset impairments and other(2)		—		—		—			—			134			134
Operating income (loss)		13,166		3,119		(91	)		3,729			(9,713	)		10,210
Other components of net periodic benefit cost		—		—		—			—			86			86
Interest expense, net		—		—		—			—			1,213			1,213
Earnings (loss) from continuing operations before income taxes	$	13,166	$	3,119	$	(91	)	$	3,729		$	(11,012	)	$	8,911
Total assets (3)	$	746,432	$	215,531	$	178,166		$	69,478		$	225,914		$	1,435,521
Depreciation and amortization		8,385		1,944		1,358			337			1,030			13,054
Capital expenditures		6,255		3,109		3,561			108			90			13,123

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2025.

(2) Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

(3) Of our $655.0 million of long-lived assets, $93.7 million and $9.8 million relate to long-lived assets in the U.K. and Canada, respectively.

Three Months Ended October 28, 2023
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	349,367	$	118,129	$	81,414		$	32,907		$	—		$	581,817
Intercompany sales elimination		—		—		(3	)		(2,499	)		—			(2,502	)
Net sales to external customers(1)		349,367		118,129		81,411			30,408			—			579,315
Segment operating income (loss)		11,975		5,484		2,706			(1,560	)		(7,654	)		10,951
Asset impairments and other (2)		—		—		—			—			99			99
Operating income (loss)		11,975		5,484		2,706			(1,560	)		(7,753	)		10,852
Other components of net periodic benefit cost		—		—		—			—			148			148
Interest expense, net		—		—		—			—			2,207			2,207
Earnings (loss) from continuing operations before income taxes	$	11,975	$	5,484	$	2,706		$	(1,560	)	$	(10,108	)	$	8,497
Total assets (3)	$	798,968	$	213,036	$	185,179		$	52,170		$	243,578		$	1,492,931
Depreciation and amortization		8,078		1,566		1,365			265			1,056			12,330
Capital expenditures		8,235		3,380		1,975			710			140			14,440

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales for the third quarter of Fiscal 2024.

(2) Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

(3) Of our $704.5 million of long-lived assets, $87.9 million and $12.9 million relate to long-lived assets in the U.K. and Canada, respectively.

Note 8

Business Segment Information, Continued

Nine Months Ended November 2, 2024
(In thousands)	Journeys Group			Schuh Group		Johnston & Murphy Group		Genesco Brands Group		Corporate & Other			Consolidated
Sales	$	920,808		$	338,736	$	228,707	$	88,941	$	—		$	1,577,192
Intercompany sales elimination(1)		—			—		—		1,921		—			1,921
Net sales to external customers(2)		920,808			338,736		228,707		90,862		—			1,579,113
Segment operating income (loss)		(16,807	)		4,562		1,861		5,415		(25,733	)		(30,702	)
Asset impairments and other(3)		—			—		—		—		1,490			1,490
Operating income (loss)		(16,807	)		4,562		1,861		5,415		(27,223	)		(32,192	)
Other components of net periodic benefit cost		—			—		—		—		281			281
Interest expense, net		—			—		—		—		3,448			3,448
Earnings (loss) from continuing    operations before income taxes	$	(16,807	)	$	4,562	$	1,861	$	5,415	$	(30,952	)	$	(35,921	)
Depreciation and amortization	$	25,545		$	5,662	$	4,136	$	982	$	3,135		$	39,460
Capital expenditures		14,059			5,606		6,737		643		352			27,397

(1) Intercompany sales for the first nine months of Fiscal 2025 reflect net intercompany returns.

(2) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2025.

(3) Asset impairments and other includes a $0.5 million charge for asset impairments in Journeys Group and $1.0 million for severance.

Nine Months Ended October 28, 2023
(In thousands)	Journeys Group			Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	908,832		$	334,033	$	241,832		$	104,232		$	—		$	1,588,929
Intercompany sales elimination		—			—		(9	)		(3,246	)		—			(3,255	)
Net sales to external customers(1)		908,832			334,033		241,823			100,986			—		$	1,585,674
Segment operating income (loss)		(21,265	)		12,110		10,178			259			(23,020	)	$	(21,738	)
Goodwill impairment(2)		—			—		—			—			28,453			28,453
Asset impairments and other(3)		—			—		—			—			581			581
Operating income (loss)		(21,265	)		12,110		10,178			259			(52,054	)		(50,772	)
Other components of net periodic benefit cost		—			—		—			—			388			388
Interest expense		—			—		—			—			6,241			6,241
Earnings (loss) from continuing    operations before income taxes	$	(21,265	)	$	12,110	$	10,178		$	259		$	(58,683	)	$	(57,401	)
Depreciation and amortization	$	23,235		$	4,751	$	3,622		$	669		$	3,172		$	35,449
Capital expenditures		32,447			9,376		5,277			1,788			850			49,738

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales for the first nine months of Fiscal 2024.

(2) Goodwill impairment of $28.5 million is related to Genesco Brand Group.

(3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.